Application

17296679 · CYCLIC PEPTIDES AS PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS

Filed 2021-05-25 · Granted · Patent 12209144 (2025-01-28) The official file ↗The patent and its PDF ↗ · Art unit 1658 · Examiner Jia-Hai Lee Hard · CPC C07K 7/08 · Novartis AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

24.1 mo

to disposition 44.2 mo

Statutes raised

112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.